{"text": ["AbbVie", "Inc.", "Is", "a", "Clear", "Value", "Play", "in", "Biotech", "Stocks"], "created_at": "2018-04-17 20:10:27"}
{"text": ["AbbVie", "Inc.", "Is", "a", "Clear", "Value", "Play", "in", "Biotech", "Stocks"], "created_at": "2018-04-17 20:10:27"}
{"text": ["Top", "Analyst", "Reports", "for", "AbbVie,", "Berkshire", "&", "PepsiCo"], "created_at": "2018-04-17 19:42:07"}
{"text": ["7", "Stock", "Picks", "With", "Giant", "Upside:", "Goldman"], "created_at": "2018-04-17 18:00:00"}
{"text": ["J&J", "(JNJ)", "Tops", "Q1", "Earnings", "Estimates,", "Raises", "Sales", "Guidance"], "created_at": "2018-04-17 16:16:31"}
{"text": ["J&J", "(JNJ)", "Tops", "Q1", "Earnings", "Estimates,", "Raises", "Sales", "Guidance"], "created_at": "2018-04-17 16:16:31"}
{"text": ["5", "Drug", "Stocks", "Poised", "to", "Surpass", "on", "Earnings", "This", "Quarter"], "created_at": "2018-04-17 15:48:03"}
{"text": ["Shire", "Sells", "Oncology", "Unit", "Ahead", "of", "Takeda's", "Potential", "Offer"], "created_at": "2018-04-17 15:16:33"}
{"text": ["Shire", "Sells", "Oncology", "Unit", "Ahead", "of", "Takeda's", "Potential", "Offer"], "created_at": "2018-04-17 15:16:33"}
{"text": ["Novartis\u2019s", "1Q18:", "Analysts", "Expect", "Revenue", "Growth"], "created_at": "2018-04-17 15:10:02"}
{"text": ["Updates", "on", "AbbVie\u2019s", "AndroGel,", "Lupron,", "and", "Kaletra"], "created_at": "2018-04-17 14:32:18"}
{"text": ["Risankizumab", "Could", "Be", "AbbVie\u2019s", "Long-Term", "Growth", "Driver"], "created_at": "2018-04-17 13:02:26"}
{"text": ["AbbVie\u2019s", "Imbruvica", "in", "4Q17", "and", "Fiscal", "2017"], "created_at": "2018-04-17 11:33:06"}
